Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
04/2014
04/09/2014CN103232449B Aztreonam compound, as well as preparation method and pharmaceutical composition thereof
04/09/2014CN102712625B Nitrogen-containing heteroaryl derivatives
04/09/2014CN102712596B Secondary 8-hydroxyquinoline-7-carboxamide derivatives
04/09/2014CN102675303B 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole and application thereof to preparation of medicaments for resisting cancer
04/09/2014CN102548965B Substituted amide compound
04/09/2014CN102532118B Indolone-containing 4-thiazolidone derivatives and application thereof
04/09/2014CN102164919B Oxazolidinyl antibiotics
04/08/2014US8691980 Salicylic acid derivatives with fluorophores and method of making and using the same
04/08/2014US8691850 Substituted phenylaminothiazoles and use thereof
04/08/2014US8691821 Oxazolidinones as modulators of mGluR5
04/08/2014US8691820 CDK inhibitors
04/08/2014US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
04/08/2014US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/08/2014US8691573 Stem cell cultures
04/08/2014CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/08/2014CA2580811C Carbostyril compound
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/03/2014WO2014052831A1 Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease
04/03/2014WO2014052365A1 Multiple kinase pathway inhibitors
04/03/2014WO2014051939A1 Phenicol antibacterial agents
04/03/2014WO2014050911A1 Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and dye-adsorbed electrode
04/03/2014WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same
04/03/2014WO2014049107A1 Compounds for use in the treatment of mycobacterial infections
04/03/2014WO2014048939A1 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
04/03/2014WO2014048853A1 Herbicidally and fungicidally active 3-heteroaryl-isoxazoline-5-carboxamides and 3-heteroaryl-isoxazoline-5-thioamides
04/03/2014WO2014048532A1 Quinazolinone derivatives as parp inhibitors
04/03/2014WO2014048355A1 Crystalline forms of dihydropyrimidine derivatives
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014048065A1 Triazolyl derivatives as syk inhibitors
04/03/2014WO2014047849A1 Cytochrome p450 monooxygenase inhibitor intermediate and preparation method and use thereof
04/03/2014WO2014015056A3 Anti-mucus drugs and uses therefor
04/03/2014US20140094610 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094608 Modified carbocyanine dyes and their conjugates
04/03/2014US20140094494 Antifungal Treatment
04/03/2014US20140094489 Heterocyclic carboxylic acid ester derivative
04/03/2014US20140094475 Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
04/03/2014US20140094466 Ssh-2 (slingshot-2) inhibitors and methods for making and using them
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094453 Sweet flavor modifier
04/03/2014US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
04/03/2014US20140093570 Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712861A1 Thioacetate compounds, compositions and methods of use
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014CN103702996A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/02/2014CN103702993A Benzamides
04/02/2014CN103702979A 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/02/2014CN103694992A Thermal activation delay fluorescent material and synthesis method thereof as well as OLED device using thermal activation delay fluorescent material
04/02/2014CN103694235A Pesticides and uses thereof
04/02/2014CN103694234A Crystal form of dihydropyrimidine derivatives
04/02/2014CN103694232A Monocyclic benzo oxazine intermediate and preparation method and use thereof
04/02/2014CN103694195A Heterocyclic aromatic micromolecule organic compounds and derivatives, preparation method and medical application
04/02/2014CN103694189A Synthesis method of 2-oxazole or 2-thiazole
04/02/2014CN102498105B Bicyclic compound and use thereof for medical purposes
04/02/2014CN102438996B Histone deacetylase inhibitors with branched structure synthesized through click chemistry
04/02/2014CN102267991B Neonicotinoid clothianidin compound, preparation method and application thereof
04/02/2014CN102264722B Dihydropyridone amides as p2x7 modulators
04/02/2014CN102180872B [1, 3 and 4] oxadiazoles derivative and application thereof
04/02/2014CN101981029B Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
04/02/2014CN101952281B Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
04/02/2014CN101821263B Dipeptoid prodrugs and the use thereof
04/02/2014CN101346357B Aminodihydrothiazine derivative
04/01/2014US8686137 Heterocyclic compounds and their uses
04/01/2014US8686008 Highly selective sigma receptor ligands
04/01/2014US8686007 Certain heterocycles, compositions thereof, and methods for their use
04/01/2014US8685975 PDE10 inhibitors and related compositions and methods
04/01/2014CA2729212C Compounds and methods for modulating g protein-coupled receptors
04/01/2014CA2654515C Substituted 3-cyanopyridines as protein kinase inhibitors
04/01/2014CA2628952C Aspartic protease inhibitors
04/01/2014CA2616377C Nitrocatechol derivatives as comt inhibitors
04/01/2014CA2581144C Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
04/01/2014CA2567404C Cyclopenta[b]benzofuran derivatives and the utilization thereof
03/2014
03/27/2014WO2014047024A1 Iap antagonists
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014US20140088148 Small molecule inhibitors of xbp1 splicing
03/27/2014US20140088127 Novel process to prepare pioglitazone via several novel intermediates
03/27/2014US20140088124 Imidazole derivatives
03/27/2014US20140088117 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/27/2014US20140088110 Fused bicyclic imidazoles
03/27/2014US20140088108 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitiors
03/27/2014US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/27/2014US20140088084 Oxazine derivatives and their use in the treatment of neurological disorders
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/27/2014US20140088076 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
03/27/2014US20140088071 sGC STIMULATORS
03/27/2014US20140086941 SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF
03/26/2014EP2709997A1 Inhibitors of bruton's tyrosine kinase
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN103687855A Imidazole derivatives
03/26/2014CN103687854A Carbonic anhydrase targeting agents and methods of using same
03/26/2014CN103664932A Indole grafted thiazole hydrazone derivatives, preparation method thereof and inhibiting effect of indole grafted thiazole hydrazone derivatives for polymerization of cancer cell microtubulin
03/26/2014CN103664931A Schiff base compound containing benzothiazole ring and imidazole ring, and preparation method thereof
03/26/2014CN103664930A Compound containing thiazole structure as well as preparation method and application of compound
03/26/2014CN103664929A Dasatinib polycrystalline form medicament and preparation method thereof
03/26/2014CN103664928A N-[5-(1,2,4-triazol-1-yl)thiazol-2-yl]fatty acid amide and application thereof
03/26/2014CN103664927A N-[5-(1,2,4-triazole-1-yl)thiazole-2-yl]aryl amide, preparation method, and applications thereof
03/26/2014CN103664926A Synthesis of pyrazoline thiazole derivatives and application of derivatives in anticancer drugs
03/26/2014CN103664925A Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines
03/26/2014CN103664915A Azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording, and inkjet recorded material
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 628